Milano, 23 October 2023 – A strategic partnership between Nikkiso Europe Group (NEG) – a company based in Hannover (Germany) and leader in developing, producing, and commercialising advanced medical devices for extracorporeal blood purification for chronic and acute care – and Estor S.p.A – a company based in Pero (Italy), specialising in advanced blood purification therapies in different clinical areas, mainly hemodialysis and intensive care, has been announced concerning the distribution of ProLUNG® Extracorporeal CO2 Removal System (Estor S.p.A – […]
